37 related articles for article (PubMed ID: 10419035)
21. Epstein-Barr virus serological markers for nasopharyngeal carcinoma in Thailand.
Puthavathana P; Sutthent R; Vitavasiri A; Wasi C; Chantarakul N; Thongcharoen P
Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):326-31. PubMed ID: 1818381
[TBL] [Abstract][Full Text] [Related]
22. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.
Ling W; Cao SM; Huang QH; Li YH; Deng MQ
Ai Zheng; 2009 Jan; 28(1):57-9. PubMed ID: 19448418
[TBL] [Abstract][Full Text] [Related]
23. The etiology of nasopharyngeal carcinoma.
de Thé G
Pathobiol Annu; 1972; 2():235-54. PubMed ID: 4589746
[No Abstract] [Full Text] [Related]
24. The enigmatic epidemiology of nasopharyngeal carcinoma.
Chang ET; Adami HO
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1765-77. PubMed ID: 17035381
[TBL] [Abstract][Full Text] [Related]
25. Nasopharyngeal carcinoma.
Andersson-Anvret M; Forsby N; Klein G
Prog Exp Tumor Res; 1978; 21():100-16. PubMed ID: 205903
[No Abstract] [Full Text] [Related]
26. Studies on nasopharyngeal carcinoma in the United States: a model for international comparisons.
Easton JM; Levine PH; Connelly RR; Day NE
Comp Immunol Microbiol Infect Dis; 1979; 2(2-3):221-8. PubMed ID: 228896
[No Abstract] [Full Text] [Related]
27. Epidemiological research into nasopharyngeal carcinoma in the Chubu region of Japan.
Takeshita H; Furukawa M; Fujieda S; Shoujaku H; Ookura T; Sakaguchi M; Ito H; Mineta H; Harada T; Matsuura H; Saito H
Auris Nasus Larynx; 1999 Jul; 26(3):277-86. PubMed ID: 10419035
[TBL] [Abstract][Full Text] [Related]
28. [Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma].
Niedobitek G
Pathologe; 1998 Sep; 19(5):337-44. PubMed ID: 9816588
[TBL] [Abstract][Full Text] [Related]
29. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
Mazeron MC
Bull Cancer Radiother; 1996; 83(1):3-7. PubMed ID: 8679277
[TBL] [Abstract][Full Text] [Related]
30. [Nasopharyngeal carcinoma: clinical and therapeutic aspects. I. Introduction and symptomatology].
Vilas Melero J; Vilas Melero J; Vilas Ribot J; Montserrat Viladiu MJ
An Otorrinolaringol Ibero Am; 1984; 11(1):19-37. PubMed ID: 6089603
[No Abstract] [Full Text] [Related]
31. The epidemiology of EBV-associated malignant diseases.
Levine PH
J Exp Pathol; 1987; 3(4):437-9. PubMed ID: 2842475
[No Abstract] [Full Text] [Related]
32. Nasopharyngeal carcinoma.
Brennan B
Orphanet J Rare Dis; 2006 Jun; 1():23. PubMed ID: 16800883
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
